DISEASE SCANNER
Global Incurable Diseases Tracker
Fibromyalgia
A chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive difficulties. Central sensitization syndrome where pain signals are amplified. Affects 2-4% of population, predominantly women.
40.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Clinical diagnosis (ACR 2016 criteria)
- 2Widespread Pain Index (WPI)
- 3Symptom Severity Scale (SSS)
- 4Exclusion of other conditions
- 5Tender point examination
- 6Sleep studies
- 7Psychological evaluation
Prognosis
Chronic condition with fluctuating course; not progressive or fatal. Quality of life significantly impaired. 30-40% achieve meaningful improvement with multimodal treatment.
Prevention
- No known prevention
- Stress management
- Regular exercise
- Good sleep hygiene
- Early treatment of triggers
Research Status
FDA-approved: Duloxetine, milnacipran, pregabalin. Low-dose naltrexone showing promise. Neuroimaging research revealing altered pain processing. Exercise and CBT remain cornerstone treatments. Research into small fiber neuropathy connection.
Affected Countries
Sources
- https://medlineplus.gov
- https://www.mayoclinic.org
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.